Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy
Open Access
- 13 October 2021
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 11 (10), 699
- https://doi.org/10.3390/metabo11100699
Abstract
SARS-CoV-2 is causing the coronavirus disease 2019 (COVID-19) pandemic, for which effective pharmacological therapies are needed. SARS-CoV-2 induces a shift of the host cell metabolism towards glycolysis, and the glycolysis inhibitor 2-deoxy-d-glucose (2DG), which interferes with SARS-CoV-2 infection, is under development for the treatment of COVID-19 patients. The glycolytic pathway generates intermediates that supply the non-oxidative branch of the pentose phosphate pathway (PPP). In this study, the analysis of proteomics data indicated increased transketolase (TKT) levels in SARS-CoV-2-infected cells, suggesting that a role is played by the non-oxidative PPP. In agreement, the TKT inhibitor benfooxythiamine (BOT) inhibited SARS-CoV-2 replication and increased the anti-SARS-CoV-2 activity of 2DG. In conclusion, SARS-CoV-2 infection is associated with changes in the regulation of the PPP. The TKT inhibitor BOT inhibited SARS-CoV-2 replication and increased the activity of the glycolysis inhibitor 2DG. Notably, metabolic drugs like BOT and 2DG may also interfere with COVID-19-associated immunopathology by modifying the metabolism of immune cells in addition to inhibiting SARS-CoV-2 replication. Hence, they may improve COVID-19 therapy outcomes by exerting antiviral and immunomodulatory effects.Funding Information
- Frankfurter Stiftung für krebskranke Kinder (n/a)
This publication has 48 references indexed in Scilit:
- Dissociation, cellular isolation, and initial molecular characterization of neonatal and pediatric human lung tissuesAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2018
- Transketolase Regulates the Metabolic Switch to Control Breast Cancer Cell Metastasis via the α-Ketoglutarate Signaling PathwayCancer Research, 2018
- Thiamine and selected thiamine antivitamins — biological activity and methods of synthesisBioscience Reports, 2018
- Transketolase Activity but not Thiamine Membrane Transport Change in Response to Hyperglycaemia and Kidney DysfunctionExperimental and Clinical Endocrinology & Diabetes, 2017
- EDIM-TKTL1/Apo10 Blood Test: An Innate Immune System Based Liquid Biopsy for the Early Detection, Characterization and Targeted Treatment of CancerInternational Journal of Molecular Sciences, 2017
- Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathwayCardiovascular Diabetology, 2016
- Antisense molecules: A new class of drugsJournal of Allergy and Clinical Immunology, 2016
- Association of transketolase polymorphisms with measures of polyneuropathy in patients with recently diagnosed diabetesDiabetes/Metabolism Research and Reviews, 2016
- The return of metabolism: biochemistry and physiology of the pentose phosphate pathwayBiological Reviews, 2014
- Evidence for altered thiamine metabolism in diabetes: Is there a potential to oppose gluco- and lipotoxicity by rational supplementation?World Journal of Diabetes, 2014